[ad_1]
Somehow it was predictable: US President Donald Trump used the promising data from Modern American Society’s crown vaccine for self-promotion. Historians should remember that these great vaccine discoveries “were all made under my supervision,” Trump tweeted. The US government has supported a number of pharmaceutical companies, including Moderna, with billions in payments and a special vaccine development program.
Shortly before Trump’s tweet, another manufacturer, American pharmaceutical company Moderna, unveiled data for its corona vaccine – 94.5 percent efficacy according to the company. The pharmaceutical supplier Lonza in Valais is said to produce the active ingredient. A production line is under construction in Visp and Lonza intends to start production there this year.
4.5 million insured doses of vaccine
The federal government has already secured 4.5 million doses of the vaccine from Moderna in August. The Federal Office of Public Health (FOPH) assumes that the first vaccinations can also be carried out in Switzerland in the first half of 2021.
Moderna vaccine can be stored for a relatively long time at normal refrigerator temperature. Agent mRNA-1273 is assumed to remain stable for 30 days at temperatures between 2 and 8 degrees, according to an announcement by Moderna on Monday.
“Another reason to hope”
US President-elect Joe Biden (77) also welcomed the progress made with Modern American Society’s corona vaccine, but at the same time urged Americans to be careful.
“Today’s news of a second vaccine is another reason for hope,” Biden tweeted. He praised those responsible for the “breakthrough” that brought people one step closer to fighting the virus. (pbe)
Source link
